About Slingshot Bioscience
Slingshot Bioscience is a company based in Berkeley (United States) founded in 2012.. Slingshot Bioscience has raised $46.38 million across 3 funding rounds from investors including Arch Venture Partners, Anterra Capital and Northpond Ventures. The company has 46 employees as of December 31, 2024. Slingshot Bioscience offers products and services including TruCytes Biomarker Controls, ViaComp Cell Health Controls, SpectraComp Compensation Controls, FlowCytes Calibration Controls, and Custom TruCytes. Slingshot Bioscience operates in a competitive market with competitors including StemoniX, InterAx Biotech, ZoBio, Magnitude Biosciences and Signal Pharmaceuticals, among others.
- Headquarter Berkeley, United States
- Employees 46 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Slingshot Biosciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$46.38 M (USD)
in 3 rounds
-
Latest Funding Round
$11 M (USD), Series A
Feb 06, 2023
-
Investors
Arch Venture Partners
& 2 more
-
Employee Count
46
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Slingshot Bioscience
Slingshot Bioscience offers a comprehensive portfolio of products and services, including TruCytes Biomarker Controls, ViaComp Cell Health Controls, SpectraComp Compensation Controls, FlowCytes Calibration Controls, and Custom TruCytes. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Cell mimics for replicating biomarkers in assays.
Assess cell viability using DNA mimics.
Provide superior compensation for flow cytometry.
Ensure instrument calibration and traceability in research.
Tailored cell mimics for specific research needs.
Unlock access to complete
Funding Insights of Slingshot Bioscience
Slingshot Bioscience has successfully raised a total of $46.38M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $11 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $11.0M
-
First Round
First Round
(14 Jun 2021)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Series A - Slingshot Bioscience | Valuation | Arch Venture Partners , Northpond Ventures | |
| Jul, 2021 | Amount | Series A - Slingshot Bioscience | Valuation | Northpond Ventures | |
| Jun, 2021 | Amount | Series A - Slingshot Bioscience | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Slingshot Bioscience
Slingshot Bioscience has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Arch Venture Partners, Anterra Capital and Northpond Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
Tech focused growth stage VC firm investing in Europe & North America
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life sciences & tech sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Slingshot Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Slingshot Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Slingshot Bioscience Comparisons
Competitors of Slingshot Bioscience
Slingshot Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as StemoniX, InterAx Biotech, ZoBio, Magnitude Biosciences and Signal Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developing a commercial scale printer for the high-volume growth and differentiation of stem cells and stem cell products.
|
|
| domain | founded_year | HQ Location |
Mutated arrestins are employed as biosensors for GPCR drug discovery.
|
|
| domain | founded_year | HQ Location |
Provider of fragment-based drug discovery services
|
|
| domain | founded_year | HQ Location |
Cell-free in vitro assays are supplied to drug discovery firms.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs regulating disease-associated genes are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Slingshot Bioscience
Frequently Asked Questions about Slingshot Bioscience
When was Slingshot Bioscience founded?
Slingshot Bioscience was founded in 2012 and raised its 1st funding round 9 years after it was founded.
Where is Slingshot Bioscience located?
Slingshot Bioscience is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Is Slingshot Bioscience a funded company?
Slingshot Bioscience is a funded company, having raised a total of $46.38M across 3 funding rounds to date. The company's 1st funding round was a Series A of $12.38M, raised on Jun 14, 2021.
How many employees does Slingshot Bioscience have?
As of Dec 31, 2024, the latest employee count at Slingshot Bioscience is 46.
What does Slingshot Bioscience do?
Slingshot Bioscience was founded in 2012 in Berkeley, United States, within the bioscience sector. Synthetic cells are manufactured using patented technology to support research in diagnostics and therapeutics. Cell-like products, including FlowCytes, are produced to replicate optical, biochemical, and physical properties of natural cells. Operations focus on enabling advancements in these fields through innovative manufacturing processes.
Who are the top competitors of Slingshot Bioscience?
Slingshot Bioscience's top competitors include Magnitude Biosciences, StemoniX and Sequence Bio.
What products or services does Slingshot Bioscience offer?
Slingshot Bioscience offers TruCytes Biomarker Controls, ViaComp Cell Health Controls, SpectraComp Compensation Controls, FlowCytes Calibration Controls, and Custom TruCytes.
Who are Slingshot Bioscience's investors?
Slingshot Bioscience has 3 investors. Key investors include Arch Venture Partners, Anterra Capital, and Northpond Ventures.